Catalyst Wire Dossier Catalyst Wire Dossier

Twynsta (telmisartan/amlodipine)

telmisartan/amlodipine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Twynsta (telmisartan/amlodipine), covering 2011-01-04 to 2011-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension [Phase 3]

See pricing